sanoid metabolism with inhibitors of 5Ј-lipoxygenase, cyclooxygenase, or epoxygenase P-450. The addition of arachidonic acid to pertussis toxin-treated membranes had no effect on the enzyme activity, indicating that arachidonic acid does not modify the GTPase activity present in G␣ s protein. However, ADP-ribosylation with cholera toxin followed by arachidonic acid treatment led to a further 40% inhibition when compared with cholera toxin treatment alone. These results allowed us to postulate that arachidonic acid inhibits the GTPase activity of G i protein family. To further analyze the mechanism of arachidonic acid inhibition of GTPase activity, the effect of arachidonic acid on the [ M OST OF the biological functions of unsaturated fatty acids are due to their ability to act as second messengers or modulators of the activities of functionally important proteins. Fatty acids can act on signal transduction pathways by direct and/or indirect means. However, several studies clearly show that fatty acids per se are messenger and modulator molecules that can mediate cell responses to extracellular signals (1) . Arachidonic acid (AA), which is esterified to the sn-2 position of membrane phospholipids, is mainly released from phospholipids by activation of phospholipase A 2 (PLA 2 ). It can be also produced by activation of: phospholipase C (PLC) followed by diacylglycerol hydrolysis by diacylglycerol lipase; phospholipase D (PLD) followed by phosphatidic acid phosphohydrolase and diacyl glycerol lipase; and finally, phospholipase A 1 (PLA 1 ) followed by lysophospholipase (2) .
In Leydig cells, steroidogenesis is regulated by LH, via cAMP and other second messengers such as calcium, chloride ions, and arachidonic acid and/or its metabolites (3, 4) . Recent results have shown that LH causes a dose-and timedependent release of arachidonic acid from Leydig cells (5).
Furthermore, arachidonic acid itself has been reported to act as an additional intracellular messenger associated with the hormonal action of LH (6 -8) . Previous results from our group have shown that in rat Leydig cells that arachidonic acid exerts a dose-and time-dependent biphasic effect on LH-and dibutryl-cAMP-stimulated testosterone production (9) . During short periods of incubation this fatty acid inhibits testosterone synthesis by decreasing cAMP levels. Recently, we have shown that arachidonic acid can modulate cAMP production through a modification of heterotrimeric G proteins which occurs mainly by activation of G i protein (10) .
It is well known that G proteins are comprised of three polypeptides: an ␣ subunit that binds and hydrolyzes GTP, a ␤ subunit, and a ␥ subunit. The ␤ and ␥ subunit form a dimer that only dissociates when it is denatured and is, therefore, a functional monomer. When GDP is bound, the ␣ subunit associates with the ␤␥ complex and forms an inactive heterotrimer that binds to the receptor. When the hormone binds to the receptor, specific types of G proteins become activated by promoting the exchange of tightly bound GDP for GTP. Once GTP is bound, the ␣ subunit assumes its active conformation and dissociates both from the receptor and from the ␤␥ complex. The activated state persists until GTP is hydrolyzed to GDP by the action of the intrinsic GTPase activity of the ␣ subunit. Once GTP is cleaved to GDP, the ␣ and ␤␥ subunit reassociate, become inactive and return to the receptor (11) . Considering that the active lifetime of G proteins depends on the rate of GTP hydrolysis, the aim of the present work was to determine if the effect of arachidonic acid on G proteins is due to a modification of its GTPase activity 
Materials and Methods

Cell isolation and purification
Leydig cells were isolated from 200 -300 g Sprague Dawley rats from the Animal House of the University of Alcala. All animals were cared for according to the guidelines of the University Committee of Animal Resources at the University of Alcalá. The testes were decapsulated and subjected to longitudinal shaking (65 strokes/min) with collagenase (0.5 mg/ml) and trypsin inhibitor (20 l/ml) for 40 min at 37 C. The cells were filtered through 60 m nylon gauze to remove fragments of seminiferous tubules and subjected to centrifugal elutriation followed by Percoll density gradient (0 -90% vol/vol) centrifugation (12) . Leydig cell purity was routinely Ͼ95%, as determined by 3␤-hydroxysteroid dehydrogenase cytochemistry (12) .
Membrane preparation
Purified Leydig cells were disrupted by freeze-thawing (4 times) in a buffer containing Tris-HCl 50 mm, pH 7.5, 3 mm EDTA, 5 g/ml soybean trypsin inhibitor, and 0.1 mm phenylmethylsulfonyl fluoride. Broken cells were centrifuged at 400 ϫ g for 2 min. at 4 C and the supernatant was centrifuged at 100,000 ϫ g for 15 min at 4 C. The final pellet containing the crude plasma membranes were suspended in the same buffer and 50 l aliquots were stored at Ϫ70 C.
Toxin treatments (PTX and CTX)
For in vitro ADP ribosylation, the toxins were activated by incubation with 100 mm DTT for 30 min at 37 C. Activated toxins were diluted in ribosylation buffer as described in Ref. 13 with 5 mm NAD. Samples were exposed to the toxins, 0.125 g PTX per 1.5 g proteins and 0.3 g CTX per1.5 g proteins for 30 min at 30 C, before performing the GTPase assays. The time course of ribosylation was followed with [ 32 P]NAD in the presence of PTX or CTX as described previously (13) . Labeled proteins were separated on SDS/PAGE gels, dried, and autoradiography was performed by exposing the gels to x-ray film. The results of these experiments indicated that a 41 kDa band was maximally labeled at 30 min with PTX treatment. At this same time, two bands with molecular weights of 50 and 52 kDa were maximally labeled with CTX and were chosen for subsequent ribosylation experiments (data not shown).
GTPase assay
Hydrolysis of [␥ 32 P]GTP was measured essentially as described by Schepers et al. (14) . Briefly, the reaction mixture (70 l) contains: 50 mm triethanolamine-HCl, pH 7.4, 1 mm dithiothreitol, 1 mm EDTA, 5 mm MgCl 2 , 100 m ATP, 100 mm NaCl, 0.4 mg/ml creatine kinase, 5 mm creatine phosphate, 2 mg/ml BSA, 1 mm ouabain, 200 nm GTP, and 30 nm [␥-32 P] GTP plus 10 l of the appropriate concentration of fatty acid or vehicle. The reaction was initiated by the addition of 20 l of membrane protein (1.5 g) to each tube (except the protein concentration experiments). The reaction was carried out at 30 C for 10 min (except for the time-course experiments) and terminated by the addition of 700 l of ice cold activated charcoal (5% in 20 mm phosphoric acid, pH 2.5) after 10 min at 4 C. Assay tubes were centrifuged for 15 min at 4 C at 3,000 ϫ g. Radioactivity in the supernatant was assayed by liquid-scintillation counting to determine the release of 32 Pi. Low-affinity hydrolysis of [␥-32 P] GTP was assessed by parallel incubation of membranes with excess (250 m) GTP. The low-affinity activity was subtracted from the total to calculate high-affinity GTPase activity. Results were expressed as pmol of Pi released per min per mg protein.
GTP␥S binding assay
Guanine nucleotide binding by G protein ␣ subunit was determined by incubating membranes (2 g of proteins) in 100 l total volume of 50 mm Tris-HCl, pH 7.4, 100 mm NaCl, 1 mm DTT, 5 mm MgCl 2, 1 mm EDTA, 0.1 m [
35 S]GTP␥S, and increasing concentrations of unlabeled GTP␥S. The reaction was carried out at 30 C for 45 min (equilibrium conditions), and samples were filtered through a Whatman GF/C filter, and washed with ice-cold (2 ϫ 2 ml) buffer consisting of 50 mm Tris-HCl pH 7.4, 5 mm MgCl 2. Nonspecific binding to proteins, assessed by quantitating the binding in the presence of 100 m unlabeled GTP␥S, was subtracted from each value to calculate the specific binding. The radioactivity bound to the filter was measured by liquid scintillation counting. The results were expressed as GTP bound (% of total radioactivity added).
The protein concentrations were determined by the method of Bradford (15), using BSA as a standard.
All data are expressed as mean Ϯ sem from, at least, three experiments, each of which was performed in duplicate. Each experiment is carried out with membranes obtained from a new isolation. Student's t test was used for statistical analysis and differences were considered significant when P Ͻ 0.05
Results
Characterization of G protein-linked GTPase activity in Leydig cell membranes
The high-affinity GTPase activity was determined by measuring the amount of 32 P released at 30 C following incubation for different time periods. The GTPase reaction was found to be linear for 15 min. (Fig. 1A) . There was also a linear relationship between membrane protein and GTP hydrolysis up to concentrations of 2 g of membrane protein, reaching a plateau with higher protein concentrations and 10 min incubation times (Fig. 1B) . Based on these findings, subsequent experiments were carried out using 1.5 g of protein and an incubation time of 10 min. Under these conditions, the basal activity was about 50 pmol per min per mg protein.
Arachidonic acid inhibition of high-affinity GTPase activity
Leydig cell membranes were preincubated with arachidonic acid (1, 50, and 100 m) for different time periods (1-10 min) and GTPase activity was determined. As illustrated in Fig. 2A , there was a time-dependent inhibition of GTPase activity both at 50 m and 100 m arachidonic acid. No inhibitory effect was found with 1 m arachidonic acid at any of the preincubation times assayed. One minute of preincubation with 100 m arachidonic acid produced approximately a 50% inhibition of the GTPase activity, whereas 2.5 min was necessary to obtain the same level of inhibition when 50 m of the fatty acid was used. A 60.5 Ϯ 3.7% (n ϭ 18) inhibition of GTPase activity was obtained when the membranes were preincubated for 5 min with 50 m arachidonic acid and these conditions were used for the subsequent experiments. The dose response effect of arachidonic acid on GTPase activity was studied using doses between 1 and 100 m and 5 min of preincubation (Fig. 2B) . This fatty acid inhibited the high-affinity GTPase activity in a concen-tration-dependent manner with an IC 50 value of 26.7 Ϯ 1.1 m. The kinetic analysis of the high-affinity GTPase activity, and its modification by arachidonic acid, was performed by employing Lineweaver-Burk plots of the data obtained as a function of GTP concentrations. A linear relationship obtaining a maximum velocity (V max ) of 3.06 Ϯ 0.3 nmol per min per mg protein was observed. A Michaelis Menten constant value (K M ) of 3.36 Ϯ 0.48 m for control membranes was also observed. Arachidonic acid at a concentration of 50 m, had no effect on the apparent affinity (K M ϭ 3.45 Ϯ 0.24 m), but produced a 40% of reduction of the maximal velocity (V max ϭ 1.88 Ϯ 0.15 nmol per min per mg protein (Fig. 3) .
Arachidonic acid modulation of high-affinity GTPase activity is direct and not mediated via its metabolites
To examine if the inhibition of GTPase activity by arachidonic acid is due to the fatty acid itself or to its transformation to active metabolites, we added inhibitors of the arachidonic acid metabolizing enzymes, namely: 5 m indomethacin for cyclooxygenase, 5 m NDGA for lipoxygenase, and 5 m Clotrimazole for epoxygenase P450 (16) together with arachidonic acid. The high-affinity GTPase activity was inhibited by arachidonic acid (50 m) by about 60%, and the same percentage of inhibition was obtained in the presence of inhibitors of arachidonic acid metabolism. The high-affinity GTPase activity was similar to control when the three in- 
FIG. 2. Arachidonic acid inhibition of high-affinity GTPase activity in
Leydig cell membranes. A, Leydig cell membranes (1.5 g) were preincubated with arachidonic acid (1, 50, and 100 M) at indicated time periods, and the high-affinity GTPase activity was determined after 10 min of incubation. B, Leydig cell membranes (1.5 g) were preincubated during 5 min with increasing concentrations of arachidonic acid (1-100 M), and the high-affinity GTPase activity was determined after 10 min of incubation. The high-affinity GTPase activity was calculated by subtracting the amount of [␥ 32 P]GTP hydrolyzed in the presence of 250 M unlabeled GTP from the total amount of 32 P released and is expressed as pmol of Pi released/min per mg protein.
All data are the mean Ϯ SEM of four separate experiments, each of which was performed in duplicate. Each experiment was carried out with membranes obtained from a new isolation hibitors were assayed together without arachidonic acid. (Fig. 4) 
Relationship between the insaturation degree and GTPase activity
The dose response inhibitory action of arachidonic acid on GTPase activity was then compared with that of other fatty acids having different degrees of unsaturation, mainly linoleic acid (18:2) and stearic acid (18:0). Arachidonic acid was the most potent inhibitor of GTPase activity with an IC 50 ϭ 26.7 Ϯ 1.1 m. For linoleic acid, the possession of only two double bonds, was apparently reflected in its diminished activity (IC 50 ϭ 34.0 Ϯ 2.3 m). Stearic acid with no double bounds, showed little effect on high-affinity GTPase activity, suggesting a role for the degree of unsaturation in the inhibition of GTPase activity (Fig. 5) .
Arachidonic acid modulates GTPase activity of G i proteins
We then studied the modification of GTPase activity after treatment of membranes with pertussis toxin (PTX). This toxin catalyzes the ADP-ribosylation of a specific cysteine residue in the G␣ i family. This covalent modification inactivates these ␣i-subunits, such that they cannot exchange GDP for GTP (17) . Under these conditions, the GTPase activity detected in the assay is only due to PTXinsensitive G proteins. In fact, the GTPase activity present in PTX-treated membranes was about 30% lower than that found in the control. The addition of arachidonic acid to PTX-treated membranes had no effect on the enzyme activity, a clear indication that arachidonic acid does not modify the GTPases activity present in PTX-insensitive G proteins such as G␣s proteins (Fig 6) . To analyze the involvement of G i proteins in arachidonic acid action, we studied the GTPase activity after treatment of membranes with cholera toxin (CTX), which catalyzes the ADP-ribosylation of a specific arginine residue in G␣ s family (17) . This covalent modification inhibits the intrinsic GTPase activity of these ␣ s -subunits so that, under these conditions, the GTPase activity detected in the assay is only due to CTX-insensitive G proteins (G␣ i proteins). As shown in Fig. 6 , ADP-ribosylation with CTX followed by arachidonic acid treatment, led to a 40% of inhibition when compared with CTX-treatment alone. These results clearly indicate that arachidonic acid inhibits the GTPase activity of the G i family of proteins. 
Lack of effect of arachidonic acid on GTP␥S binding
The inhibitory effect of arachidonic acid on GTPase activity might be due to either direct effects on the intrinsic GTPase itself, or a decrease in GTP binding. To test this second possibility, we studied the [ 35 S]GTP␥S binding in Leydig cell membranes. Under optimized conditions, GTP␥S binding was linear up to a protein concentration of 5 g/tube and was also time dependent (at 30 min; data not shown). Increasing concentrations of GTP competitively inhibited [ 35 S]GTP␥S binding to membranes and arachidonic acid had no effect on this binding. Thus, inhibition of GTPase activity by arachidonic acid cannot be attributable to an inhibition in GTP binding (Fig. 7) .
Discussion
Previous results from our group have indicated that inhibition of steroidogenesis by arachidonic acid in Leydig cells result from a suppression of hormone-stimulated cAMP levels by activation of G i proteins (10) . In the present work, we have characterized the high-affinity GTPase activity of G proteins in Leydig cell membranes and their regulation by arachidonic acid. Several reports have postulated that arachidonic acid regulates GAP (GTPase activating protein)-stimulated GTPase activity, with important regulatory effect on cellular function (18 -23) . However, little is known about the regulation of high-affinity GTPase activity by fatty acids.
Our present results clearly indicate that arachidonic acid produces a time-and dose-dependent inhibition of highaffinity GTPase activity with an IC 50 of 26.7 m. In fetal guinea-pig lung membranes, arachidonic acid seems to play an important role in the developing organ by decreasing GTPase activity (16) , but with a IC 50 ϭ 48 m. In rat and human islet membranes (24) , high arachidonic acid concentrations (330 m) produce insulinotropic effects due, in part, to its ability to maintain G proteins in their active configuration by decreasing GTP hydrolysis.
It is well know that arachidonic acid acts indirectly via its metabolites (21) , and directly by modulating G protein-mediated signals (2, 18, 20) . In this context, our results clearly indicate that the action of arachidonic acid on G proteins in Leydig cell membranes is direct and not due to its transformation to its active metabolites, because the inhibitory effect is not reversed in the presence of arachidonic acid metabolism inhibitors. This is consistent with our previous report showing that arachidonic acid itself decreases the LH-stimulated cAMP production in Leydig cells (9) and by others, indicating that unsaturated fatty acids can interact with signaling proteins in vitro and modulate their activities. For example, arachidonate and related unsaturated fatty acids physically associate with and inhibits the activity of the Ras GTPase activating protein known as GAP (20) . Such lipids can also regulate the association of the Ras-related protein, Rac, with a specific GDP dissociation inhibitor (18) . In addition, an apparent relationship between the potency of fatty acid inhibition of GTPase activity and the number of double bonds in the fatty acid molecule has been noted by other workers and is consistent with the data presented herein. For example, when bacterially synthesized c-Ha-ras protein (Ras) was incubated with GTPase-activating protein in the presence of saturated or unsaturated fatty acids, 150 m arachidonic acid blocked GTPase-activating protein activity by 88%, whereas linoleic acid (18:2) was 33% inhibitory and saturated fatty acids (palmitic, stearic) showed no effect at similar concentrations (20) .
The GTPase assay, performed in ADP-ribosylated membranes, clearly indicated that arachidonic acid acts on a CTXinsensitive (PTX-sensitive) G i family of proteins. The mechanism by which arachidonic acid inhibits GTPase activity is still not known, but present results indicate that affinity for GTP is unaffected by arachidonic acid (similar K M ). Furthermore, this fatty acid does not affect GTP binding at the guanine nucleotide-binding pocket of the ␣-subunit (Fig. 7) . Similarly, Kowluru and Metz (24) found that the inhibition of GTPase activity in pancreatic islet subcellular fractions by lipids could not be attributable to a mere reduction of GTP␥S binding. However, arachidonic acid suppresses guanine nucleotide binding to the ␣-subunit of Gz (22) . Our finding of a significant effect of arachidonic acid (IC 50 26.7 m) at levels much below the critical micellar concentration for arachidonic acid [73 m (22) ] supports the notion that arachidonic acid interaction with membrane proteins is unlikely to be micelle-dependent as suggested for arachidonic acid-recombinant G z interaction (22) . The precise mechanisms whereby the FFA affect specific biological functions is at present unknown. Nevertheless, the concept of membrane lipid structural heterogeneity, i.e. lipid domains, is now well accepted (25) . The concept that organization of the lipid component of membranes into domains permits one to postulate that specific membrane proteins reside in specific lipid domains. It is reasonable to assume that perturbations of specific domain structure by arachidonic acid could affect G protein structure and function, as it has been postulated by others (25, 26) .
Previous results from our group have indicated that arachidonic acid inhibits LH-stimulated cAMP production in Leydig cells (9) by activation of a G i protein (10) . The results presented in this paper indicate that arachidonic acid inhibits the GTPase activity of G i proteins without a modification of GTP binding. This implies that arachidonic acid maintains G i proteins in their activated state, and thereby, are able to inhibit adenylate cyclase. It is reasonable to postulate that this could be the molecular mechanism by which arachidonic acid decreases the LH-stimulated cAMP and testosterone accumulation previously reported by us (9, 10). It is not completely clear whether the LH receptor is coupled to G i , but several reports have indicated that G i , in addition to G s , may also has a role in the control of Leydig cell cAMP production (27) (28) (29) . More recently Rajagopalan-Gupta et al. (30) have demonstrated that activation of LH receptor promotes activation of G␣ i in addition to G␣ s . Therefore, the present results together with those indicating that arachidonic acid is released after LH-receptor interaction (5) clearly point out the mechanism by which arachidonic acid acts as a second messenger in steroidogenesis in Leydig cells.
